10x Genomics
254 hedge funds and large institutions have $3.75B invested in 10x Genomics in 2023 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 80 increasing their positions, 99 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
254
Holders Change
-17
Holders Change %
-6.27%
% of All Funds
4.05%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
33
Increased
80
Reduced
99
Closed
48
Calls
$41.1M
Puts
$8.98M
Net Calls
+$32.2M
Net Calls Change
+$21.3M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$188M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$29.7M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$19.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$14.6M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$53.5M |
| 2 |
SIM
SRS Investment Management
New York
|
-$46.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$29.1M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$19.9M |
| 5 |
GIM
Generation Investment Management
London,
United Kingdom
|
-$19.7M |
